MYH9 and neuroblastoma: In addition to its predicted targeting of MYH9, miR-124-3p was predicted to target additional cytoskeletal genes (PLEC, ITGB1, VIM, and ACTN4) from our panel, which were overexpressed in the resistant SK-N-ASCis24 neuroblastoma cell model.